Name | 4-(4-Chlorophenyl)cyclohexanecarboxylic acid |
---|---|
Synonyms |
4-(4'-CHLOROPHENYL)CYCLOHEXANCARBOXYLIC ACID
1,4-Dioxaspiro[4.5]dec-7-ene,8-(4-chlorophenyl) 4-(4-chlorophenyl)cyclohexane-1-carboxylic acid trans-4-(4-chlorophenyl) cyclohexane carboxylic acid trans-4-(p-chlorophenyl)cyclohexane carboxylic acid 4-(4-chlorophenyl)cycIohex-3-enone monoethylene ketal 4-(4'-CHLOROPHENYL)CYCLOHEXANCARBOXYLICACID 4-(4-Chlorophenyl)cyclohexane carboxylic acid 4-(4-CHLOROPHENYL)CYCLOHEXYLCARBOXYLIC ACID 4-(4-CHLOROPHENYL) CYCLOHEXANECARBOXYLIC ACID 4-(4-chlorophenyl)cyclohex-3-enone monoehtylene ketal (E)-4-(4-chlorophenyl)cyclohexanecarboxylic acid 4-(4-Chlorophenyl)cyclohexanecarboxylic acid 4-(4-chlorophenyl)-cyclohexanecarboxylic acid Cyclohexanecarboxylic acid, 4-(4-chlorophenyl)- 4,4-DIMETHYL-6-ETHYNYLTHIOCHROMAN DIO006 MFCD00665919 TRANS-4-(4-CHLOROPHENYL)CYCLOHEXANE CARBOXYLIC ACID |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 387.1±42.0 °C at 760 mmHg |
Melting Point | 250-255ºC |
Molecular Formula | C13H15ClO2 |
Molecular Weight | 238.710 |
Flash Point | 187.9±27.9 °C |
Exact Mass | 238.076050 |
PSA | 37.30000 |
LogP | 3.83 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.561 |
Synonym: Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
Not available. Potential Health Effects Eye: May cause eye irritation. Skin: May cause skin irritation. May be harmful if absorbed through the skin. Ingestion: May cause irritation of the digestive tract. May be harmful if swallowed. Inhalation: May cause respiratory tract irritation. May be harmful if inhaled. Chronic: Not available. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Get medical aid. Wash mouth out with water. Inhalation: Remove from exposure and move to fresh air immediately. Notes to Physician: Treat symptomatically and supportively. Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Section 7 - HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Use adequate ventilation to keep airborne concentrations low. Exposure Limits CAS# 95233-37-7: Personal Protective Equipment Eyes: Not available. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: white Odor: Not available. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 255 - 257 deg C Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C13H15ClO2 Molecular Weight: 238.71 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Not available. Conditions to Avoid: Incompatible materials. Incompatibilities with Other Materials: Oxidizing agents, reducing agents. Hazardous Decomposition Products: Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide, acrid smoke and fumes. Hazardous Polymerization: Has not been reported Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 95233-37-7 unlisted. LD50/LC50: Not available. Carcinogenicity: 4-(4-Chlorophenyl)cyclohexanecarboxylic acid - Not listed by ACGIH, IARC, or NTP. Section 12 - ECOLOGICAL INFORMATION Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA No information available. IMO No information available. RID/ADR No information available. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 95233-37-7: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 95233-37-7 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 95233-37-7 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
Hazard Codes | Xi:Irritant; |
---|---|
Risk Phrases | R36/37/38 |
Safety Phrases | S22-S26-S36/37/39 |
HS Code | 2916399090 |
~% 95233-37-7 |
Literature: Journal of Medicinal Chemistry, , vol. 16, # 7 p. 813 - 823 |
~% 95233-37-7 |
Literature: Journal of Medicinal Chemistry, , vol. 16, # 7 p. 813 - 823 |
~% 95233-37-7 |
Literature: Journal of Medicinal Chemistry, , vol. 16, # 7 p. 813 - 823 |
Precursor 2 | |
---|---|
DownStream 2 | |
HS Code | 2916399090 |
---|---|
Summary | 2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |